REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$661.97
Tradestie Score
64
Market Cap
$63.59B
P/E Ratio
16.2
Revenue Growth
0.2%
Analyst Upside
+24.2%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$481.79
|
$103.64B | 29.6 | 57 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$289.33
|
$60.38B | 81.2 | 60 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$876.65
|
$46.96B | 40.3 | 56 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$304.00
|
$36.81B | 68.5 | 54 | Compare |
|
INSM
Insmed, Inc.
|
$109.31
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.93
|
$24.57B | - | 55 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$208.35
|
$22.61B | 21.4 | 59 | Compare |
|
GMAB
Genmab A/S ADS
|
$29.21
|
$19.56B | 22.4 | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.07
|
$16.93B | 16.6 | 57 | Compare |
|
ILMN
Illumina Inc
|
$189.31
|
$15.72B | 34.1 | 60 | Compare |
More REGN Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry